Addressing the needs of a growing patient group: geriatric oral drug delivery strategies
18th November 2015 | 3AM ET / 8AM GMT / 9AM CET / 5PM SGT | Dr. Carsten Timpe & Dr. Sigrid Pieters |WATCH THIS FREE ON DEMAND WEBINAR
Dr Carsten Timpe is currently a Senior Principal Scientist at Hoffman La Roche AG in Basel Switzerland, focusing on early drug development. Previously he held positions at Novartis, Lilly and Schering/Jenapharm.
Dr Timpe has 20 years of experience in solid dosage form development from early to late stage and is the inventor/co-inventor of multiple international formulation patents.
Dr Timpe completed his Ph.D thesis in Pharmaceutical Chemistry at the Phillips University Marburg, Germany.
Since 2013 Dr. Sigrid Pieters has been working as a Scientist in the Pharmaceutical Technical Development department of F. Hoffmann-La Roche in Basel, Switzerland. She obtained a master degree in Pharmaceutical Sciences and a master after master degree in Industrial Pharmaceutical Sciences, both at the Free University of Brussels. She obtained her PhD at the same university, in cooperation with the University of Ghent in Belgium. Her daily work at Roche includes the formulation and process development of solid oral dosage forms for New Chemical Entities. She is particularly interested in patient-centric formulations, Quality by Design and Process Analytical Technologies.